Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

BL 3459

Known as: BL-3459 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1981
1981
Comparison of sulfinpyrazone and BL-3459 with S - 20344, a potent new antithrombotic agent.
Abstract We wish to report the discovery of a new class of compounds, the nitrooxazoles, which demonstrate potent antithrombotic… Expand
Is this relevant?
1979
1979
Antiplatelet drugs and the generalized Shwartzman reaction in the pregnant rat.
Several antiplatelet drugs (aspirin, sulfinpyrazone, hydroxychloroquine, dipyridamole, BL-3459, pyridinolcarbamate) were assayed… Expand
Is this relevant?
1979
1979
Evaluation of antiinflammatory and antithrombotic drugs in pulmonary and arterial thrombosis.
Abstract The antithrombotic effect of five nonsteroidal antiinflammatory drugs (NSAID) and four experimental antithrombotic… Expand
Is this relevant?
1977
1977
Enhanced platelet aggregability in dogs following myocardial infarction.
Abstract Coronary artery ligation in beagle dogs led to an abnormal platelet response that may be similar to that observed in… Expand
Is this relevant?
1976
1976
The effect of a potent inhibitor of platelet aggregation, BL-3459, on adrenaline-induced myocardial necrosis in beagle dogs.
The effect of a potent inhibitor of platelet aggregation, BL-3459, on adrenaline-induced myocardial necrosis was investigated in… Expand
Is this relevant?
1975
1975
Pharmacology of a potent, new antithrombotic agent, 6-methyl-1,2,3,5-tetrahydroimidazo[2, 1-b] quinazolin-2-one hydrochloride monohydrate.
The effect of 6-methyl-1,2,3,5-tetrahydroimidazo[2,1-b] quinazolin-2-one hydrochloride monohydrate (BL-3459) on platelet function… Expand
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE